Clinical trial · Observational
Siewert Type II Esophageal Adenocarcinoma: Relationship Between Histology and Survival
Siewert Type II Esophageal Adenocarcinoma: on the Relationship Between Histology, Esophageal-gastric Intestinal Metaplasia and Gastric Greater Curvature Lymphatic Metastases, Survival
NCT03416101CI-TRIAL-00031432SiewertIIEACcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In Siewert type II adenocarcinoma, the relationship between adenocarcinoma sub types and survival, histologic/biologic patterns related to the presence/absence of gastric greater curvature metastases, were investigated.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Siewert Type II Adenocarcinoma of Esophagogastric Junction | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Total Gastrectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Survival
- timeFrame
- 5 years
- description
- 5 year survival between intestinal and diffuse types (Lauren's classification) of Siewert type II adenocarcinoma after primary surgery,
Secondary outcomes (1)
- measure
- Frequency of gastric greater curvature lymph nodes metastases in Siewert II adenocarcinoma
- timeFrame
- 5 years
- description
- Frequency of gastric greater curvature lymph nodes metastases and survival
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: Siewert type II adenocarcinoma \> 18 year submitted to primary surgery Exclusion Criteria: Siewert type II adenocarcinoma submitted to neoadjuvant therapy. Siewert type I adenocarcinoma. Siewert type III adenocarcinoma Squamous Carcinoma \-
References
Publications (0)
Data not yet available
No reference posted for this study.